CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Similar documents
Wirral COPD Prescribing Guidelines

THE COPD PRESCRIBING TOOL

Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health

Medicines Management of Chronic Obstructive Pulmonary Disease (COPD)

If you require this document in another format such as Braille, large print, audio or another language please contact the Trusts Communications Team

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES

COPD Update. Plus New and Improved Products for Inhaled Therapy. Catherine Bourg Rebitch, PharmD, BCACP Clinical Associate Professor

Up in FLAMES: Stable Chronic Obstructive Pulmonary Disease (COPD) Management. Colleen Sakon, PharmD BCPS September 27, 2018

STRIVERDI RESPIMAT (olodaterol hcl) aerosol

Co. Durham & Darlington Respiratory Network COPD Treatment Guide

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes

Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines

Prescribing guidelines: Management of COPD in Primary Care

COPD. Breathing Made Easier

CHARM Guidelines for the diagnosis and

COPD. Understanding. An educational health series from National Jewish Health IN THIS ISSUE. What is COPD? 2. How is COPD Managed?

Better Living with Obstructive Pulmonary Disease A Patient Guide

Respiratory Health. Asthma and COPD

QUANTITY LIMIT CRITERIA. BROVANA (arformoterol tartrate) SEREVENT DISKUS (salmeterol) STRIVERDI RESPIMAT (olodaterol)

Algorithm for the use of inhaled therapies in COPD Version 2 May 2017

NHS Dumfries & Galloway Triple therapy in COPD patients over 16 years

Algorithm for the use of inhaled therapies in COPD

Choosing an inhaler for COPD made simple. Dr Simon Hart Castle Hill Hospital

2017 GOLD Report. Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017

Respiratory Inhalers. Identification Guide Version 3

Presented by UIC College of Nursing

Chronic Obstructive Pulmonary Disease 1/18/2018

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

Pharmacotherapy for COPD

Chronic obstructive pulmonary disease

Address Comorbidities

COPD. Helen Suen & Lexi Smith

A Visual Approach to Simplifying Respiratory Drug Regimens

Why should I read this booklet?

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens

Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health

COPD Prescribing Guidelines

INHALERS for COPD INTRODUCTION. Types of inhalers. Inhaler technique. MDIs for COPD WET AEROSOLS. Dr Christopher Worsnop

Medications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources

Medicines Management Programme Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD)

Clinical Policy: Roflumilast (Daliresp) Reference Number: CP.PMN.46 Effective Date: Last Review Date: 08.18

Exacerbations of COPD. Dr J Cullen

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 15 December 2010

Common Drug Review Pharmacoeconomic Review Report

PATIENT INFORMATION Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet

Three s Company - The role of triple therapy in chronic obstructive pulmonary

COPD: Preventable and Treatable. Lecture Outline. Diagnosis of COPD. COPD: Defining Terms

Asthma COPD Update 2018

Test Your Inhaler Knowledge

Defining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist

COPD The New Epidemic. Peter Lin MD CCFP Director Primary Care Initiatives Canadian Heart Research Centre

COPD: Treatment Update Property of Presenter. Not for Reproduction. Barry Make, MD Professor of Medicine National Jewish Health

VA/DoD Clinical Practice Guideline Management of COPD Pocket Guide

COPD: Current Medical Therapy

Surveillance report Published: 6 April 2016 nice.org.uk. NICE All rights reserved.

Changing Landscapes in COPD New Zealand Respiratory Conference

What is New in COPD: Times Are Changing! Meredith Chiasson, MD, FRCPC April 6, 2018

Chronic Obstructive Pulmonary Disease

MANAGING ASTHMA. Nancy Davis, RRT, AE-C

Air Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.

II: Moderate Worsening airflow limitations Dyspnea on exertion, cough, and sputum production; patient usually seeks medical

COPD. Definitionn. make. when (bronchioles) in. the lungs. Wheezing Chest tightness. your lungs. greenish. Lack of energy

umeclidinium/vilanterol, 55/22 micrograms, inhalation powder (Anoro ) SMC No. (978/14) GlaxoSmithKline

Guideline for the Diagnosis and Management of COPD

COPD Robert Schilz DO, PhD Pulmonary, Critical Care and Sleep Medicine University Hospitals Case Medical Center

Nancy Davis, RRT, AE-C

SABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA

Dose. Route. Units. Given. Dose. Route. Units. Given

THEOPHYLLINE WITH INHALED CORTICOSTEROIDS (TWICS) TRIAL SELF MANAGMENT / ACTION PLANS GENUAIR INHALERS: POTENTIAL SAFETY ISSUE

HSN S FORMULARY ALTERNATIVES FOR STABLE COPD. Which drug comes with which device?

Medical Directive. Activation Date: April 24, 2013 Review due by: December 1, Medical Director: Date: December 1, 2017

ASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides

GMMMG COPD Formulary Inhaler Options October 2017

information Chronic Obstructive Pulmonary Disease - COPD (1 of 5) What is COPD? What is going on in my lungs? What are the symptoms of COPD?

Asthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.

umeclidinium, 55 micrograms, powder for inhalation (Incruse ) SMC No. (1004/14) GlaxoSmithKline

Medicines Management of Chronic Obstructive Pulmonary Disorder (COPD)

Medications Affecting The Respiratory System

New and Novel Medications for Respiratory Care

What is this patient s diagnosis?

COPD COPD. C - Chronic O - Obstructive P - Pulmonary D - Disease OBJECTIVES

Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

aclidinium 322 micrograms inhalation powder (Eklira Genuair ) SMC No. (810/12) Almirall S.A.

COPD 2016 What to do with all these New Inhalers?

12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing

FDCs for CO PD: From Famine to a Feast of Therapeutic Choices

Bronchial asthma. MUDr. Mojmír Račanský Odd. Alergologie a klinické imunologie FNOL Ústav Imunologie LF UPOL

COPD Update: Focus on Intensifying LABA, LAMA and ICS Therapy

Respiratory Pharmacology

Evidence Review for Prescribing Clinical Network

Update on Pulmonary Diseases. Jeffrey Lessar, MD

RESPIRATORY CARE IN GENERAL PRACTICE

Chapter 7. Anticholinergic (Parasympatholytic) Bronchodilators. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

COPD Respiratory Antimuscarinics Drug Class Monograph

History & Development

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Summary of the risk management plan (RMP) for Laventair (umeclidinium bromide and vilanterol)

These lung function tests involve you being seated and breathing into specialist equipment (like that shown below), via a filter and a mouthpiece.

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS

Transcription:

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

INCIDENCE UP TO 380,000 PEOPLE IN IRELAND HSE FIGURES 110,000 DIAGNOSED AND 200,000 UNDIAGNOSED. AFFECTS MORE MEN THAN WOMEN BUT RATES ARE RISING 1500 DEATHS PER YEAR

WHAT IS COPD? PROGRESSIVE DISEASE THAT MAKES IT DIFFICULT TO BREATHE ITS AN UMBRELLA TERM USED TO DESCRIBE PROGRESSIVE LUNG DISEASES INCLUDING EMPHYSEMA, CHRONIC BRONCHITIS CHARACTERISED BY INCREASING BREATHLESSNESS

SYMPTOMS CHRONIC COUGH WHEEZING SHORTNESS OF BREATH FATIGUE RECURRENT RESPIRATORY INFECTIONS WEIGHT LOSS MORNING HEADACHES SWOLLEN FEET AND ANKLES

GRADES O- ONLY SOB DURING OR AFTER STRENUOUS EXERCISE 1- SOB WHEN HURRYING. COUGH OR MUCUS NOT USUSALLY PRESENT. PFT 80% OF PREDICTED RESPONSE 2-SOB ON LEVEL SURFACES.STOP FOR RESTS TO CATCH BREATH. COUGH OR MUCUS MAY BE PRESENT. MANY FIRST SEEK MEDICAL CARE AT THIS STAGE. PFT 50-80%

GRADES 3- STOP TO REGAIN BREATH AFTER ONLY A FEW MINUTES OF WALKING ON A LEVEL SURFACE. COUGH AND MUCUS PRESENT. EXERCISE VERY DIFFICULT AT THIS POINT. INCREASED FATIGUE AND QUALITY OF LIFE BEGINS TO SUFFER. PFT 30-50% 4- TOO BREATHLESS TO LEAVE HOUSE. SOB DURING EVERYDAY ACTIVITIES.TROUBLE BREATHING MAY BE LIFE THREATHENING DURING SOME EPISODES. PFT LESS THAN 30%

CAUSES CIGARETTE SMOKING 80-90% LONG TERM EXPOSURE TO LUNG IRRITANTS AIR POLLUTION CHEMICAL FUMES DUST HEREDITARY

Treatments Lifestyle changes- 1. Quit smoking 2. Avoid second hand smoke and fumes 3. Healthy diet and water consumption 4. Exercise- check with doctor 5. Breathing exercises- physio 6. Relaxation and Mindfulness

Medicines Beta 2 agonists 1. Short acting- salbutamol (Ventolin) 2. Long acting- salmeterol, formoterol,vilanterol and indacaterol Mechanism of action- Relaxes the smooth muscle of the bronchioles and relieves bronchospasm. They also facilitate expectoration.

Indacaterol (Onbrez) Long acting Beta 2 agonist, once daily dosing Maintenance bronchodilation Administer at the same time of day Acts locally in the lungs to relax bronchial muscle and aid bronchodilation. Technique Beta 2 agonists

Anticholinergics Anticholinergics prevent bronchoconstriction( airways tightening) and helps clear mucus. Short acting- Ipratropium (Atrovent) Long acting- Tiotropium (Spiriva) - Umeclidinium (Incruse Ellipta) - Glycopyrrolate (Seebri)

Tiotropium Long Acting anti muscarinic Handihaler is once daily dosing Significant clinical benefit Respimat dose

Long acting anti muscarinic Once daily dosing Longer duration of action Causes relaxation of airway muscle, improved lung function and decreased mucus secretion Umeclidinium

Glycopyrrolate Long acting anti muscarinic Once daily dosing Long term maintenance treatment

Combination of LABA and LAMA

Combination therapy LAMA and LABA Umeclidium and vilanterol (Anoro Ellipta) Once daily dosing Glycopyrrolate and Vilanterol (Ultibro) Once daily dosing

Corticosteroids Inhibits bronchoconstriction, induces muscle relaxation. Decreases inflammatory cells in turn decreasing airway hyper responsiveness Use of oral steroids in the treatment of acute exacerbations is widely accepted and recommended. Nebules and inhalers

Steroid and Beta 2 agonist Indicated when COPD is uncontrolled with bronchodilation monotherapy. Budesonide and Formoterol (Symbicort) Twice daily or PRN? Fluticasone and Vilanterol (Relvar Ellipta) Once daily dosing combination

Other therapies Nebules- Available in short acting beta 2 agonists and short acting anticholinergics, Steroids and Saline. Side effects?? Xanthine derivatives- Theophylline Limited to use as an adjunctive Narrow therapeutic Index Side effects and Interactions

Antibiotics Azithromycin Used to treat acute bacterial exacerbations of COPD caused by a variety of bacteria. Offers decreased GI upset Increased compliance through reduced dosing frequency. Anti inflammatory properties Dose?

Mucolytics Carbosysteine Available as cough bottle Exputex Dose Erdosteine Capsules 300mg twice daily for max 10 days

Alternative therapies Breathing Exercise Physio Helps control breathlessness associated with COPD Helps prevent panic when you feel short of breath Relaxation and Mindfulness Video on COPD support website Helps prevent anxiety around shortness of breath Takes practice and patience!!

References Copdfoundation.org Copd society Medline plus Nhlibi.nih.gov Healthline.com Nhs.uk/copd